Navigation Links
Specialised Therapeutics Australia Partners with Genomic Health Inc. to Deliver Novel Genomic Test to Breast Cancer Patients
Date:1/7/2014

MELBOURNE, Australia, Jan. 7, 2014 /PRNewswire/ -- Australian women will potentially have greater access to the only genomic test validated to predict whether patients with early-stage invasive breast cancer would benefit from chemotherapy, following an agreement between Specialised Therapeutics Australia (STA) and Genomic Health, Inc. (NASDAQ: GHDX).

STA has struck an agreement to represent the important diagnostic technology known as the Oncotype DX Breast Cancer Assay from Genomic Health, the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early stage cancer.

The Oncotype DX test is a 21 gene assay that predicts a patient's likely benefit from chemotherapy and the overall risk of breast cancer recurrence. This technology has been shown to guide treatment decisions, sparing patients the impact of unnecessary chemotherapy while identifying those patients who may benefit from this additional treatment.

Under the terms of the agreement, STA will undertake all commercial operations including sales and marketing of the product within Australia as well as providing product support and practitioner education.

As part of this agreement, STA has partnered with Healthscope Pathology who will continue to oversee logistics in Australia, including tissue sample management.

Announcing the distribution agreement with Genomic Health, STA Chief Executive Officer Carlo Montagner said the Oncotype DX assay was a high calibre tool for women diagnosed with early stage breast cancer who sought to avoid chemotherapy where possible, because it provided information about the likelihood of a cancer recurrence.

"This ground breaking test, which has been universally adopted in the U.S., helps women make informed decisions," he said.

"Many Australian women wi
'/>"/>

SOURCE Specialised Therapeutics Australia Pty Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
2. Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics
3. Shield Therapeutics ST10 Delivers Robust Results Meeting both Primary and Secondary Endpoints in the Pivotal AEGIS Phase 3 Programme for the Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease
4. PTC Therapeutics To Present At The J.P. Morgan Healthcare Conference
5. Mast Therapeutics Announces Positive Data In Model Of Heart Failure
6. Moderna Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference
7. Aratana Therapeutics Acquires Okapi Sciences NV
8. Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat
9. Mederi Therapeutics Closes Funding of $18.5 Million
10. Aratana Therapeutics Provides 2013 Development Update
11. 2013 Report on the International Pain Management Therapeutics Market - Includes Forecast to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... International Inc. (NYSE: MTD ) today announced ... highlights: , Sales in local currency increased ... year. Reported sales increased 5% which included a 1% ... share as reported (EPS) were $2.49, compared with $2.24 ... $2.57, an increase of 9% over the prior-year amount ...
(Date:7/24/2014)... BUENA, N.J. , July 24, 2014 ... New Jersey based specialty generic pharmaceutical company, ... resignation from its Board of Directors.  Mr. Finio has ... company, and under the terms of his acceptance of ... continue in his role as Director for IGI Laboratories, ...
(Date:7/24/2014)... , July 24, 2014  Alimera Sciences, Inc. ... that specializes in the research, development and commercialization of ... its second quarter of fiscal year 2014 financial results ... An investor conference call will follow on the same ... conference call will be hosted by Dan Myers ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2Alimera Sciences To Release Second Quarter 2014 Results 2
... , CLEVELAND, Nov. 30 DATATRAK International, Inc. (OTCQX: ... solutions for the clinical trials industry, today announced that PFC ... PFC will now have the ability to contract for DATATRAK,s ... product suite. In addition, PFC will also have access ...
... Breast-Specific Gamma Imaging (BSGI) has been proven to be ... carcinoma in situ (DCIS), a difficult to diagnose breast cancer. ... lesions independent of tissue density and discover very early stage ... of the Radiological Society of North America (RSNA), BSGI is ...
Cached Medicine Technology:PFC Pharma Joins DATATRAK's CRO Connect Program 2PFC Pharma Joins DATATRAK's CRO Connect Program 3PFC Pharma Joins DATATRAK's CRO Connect Program 4Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2
(Date:7/24/2014)... Voted one of the most reliable online dress ... on providing its new and old customers with the ... has announced its new collection of high end wedding ... according to the latest fashion trends. Additionally, they are ... , As a matter of fact, high end special ...
(Date:7/24/2014)... July 24, 2014 Four Seasons ... month of its $3 million renovation of the famed ... presidential/residential three-bedroom suites, just in time to welcome summer ... With design direction from the internationally-acclaimed BraytonHughes Design Studios, ... on the property and the largest in Hawaii—received a ...
(Date:7/24/2014)... By Amy Norton HealthDay ... stereotype of the sex-crazed teenage boy may be dead wrong, according ... from romantic relationships. In interviews with 33 boys between the ... wanted a relationship with a girl for the closeness and trust. ... "main goal" in starting a relationship with a girl. "In ...
(Date:7/24/2014)... mellitus (DM) appears to increase the risk for head and ... in people with DM, but the risk of HNC in ... and neck cancer is the sixth most common type of ... and for an estimated 650,000 new cancer cases and 350,000 ... Longitudinal Health Insurance Research Database to examine the risk of ...
(Date:7/24/2014)... July 24, 2014 This year the ... Light Electric and Jackson National Life, will be held on ... 7 am, the Kids Fun Run at 7:50 am, the ... at 9 a.m. , “The Walk to End Alzheimer’s unites ... dedication in the fight against this devastating disease, “stated Linda ...
Breaking Medicine News(10 mins):Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 2Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 3Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 4Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 5Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 3
... standard Prostate Specific Antigen (PSA) test for prostate cancer ... At the Annual EAU Congress, which will be held ... Dr. Arun Sreekumar - University of Michigan (US) - ... supposedly discriminate between aggressive and non-aggressive prostate cancers: sarcosine. ...
... Peripheral Arterial Disease Patients at High Cardiovascular Risk ... 6,200-Person NHANES StudySAN DIEGO, Calif., March 10 ... tests--like the ankle brachial index (ABI)--along with traditional ... the potential to prevent devastating heart attacks in ...
... Help Peripheral Arterial Disease (PAD) Patients With Critical ... Attempts to treat critical limb ischemia in ... are still thwarted by restenosis (the re-narrowing of ... stenting), the need for repeat treatments and the ...
... Certification Underscores Lionbridge,s Market-Leading Translation Management Program ... 10 Lionbridge (Nasdaq: LIOX ... ISO 13485:2003 certification which verifies quality management ... expands Lionbridge,s dedicated Life Sciences program and ...
... Conference Call to Follow ReleaseDENVER, March 10 ... "Company") (OTC Bulletin Board: GLOB), an international e-Health, ... quarter and year end financial results on Wednesday, ... The Company will host a conference call at ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced ... Officer of BioMarin, will present a company update at the ... on Tuesday, March 17th, 2009 at 9:30 a.m. ET. ... conference call via the investor section of the BioMarin website, ...
Cached Medicine News:Health News:Dr. Arun Sreekumar lectures on new candidate biomarker at Annual EAU Congress 2Health News:Simple Test Helps Predict Heart Attack Risk 2Health News:Simple Test Helps Predict Heart Attack Risk 3Health News:Simple Test Helps Predict Heart Attack Risk 4Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 2Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 3Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 4Health News:Lionbridge Receives ISO 13485:2003 Certification for Quality Management 2Health News:Global Med Technologies(R), Inc. to Report Fourth Quarter and Year End Financial Results on Wednesday, March 25, 2009 2Health News:Global Med Technologies(R), Inc. to Report Fourth Quarter and Year End Financial Results on Wednesday, March 25, 2009 3Health News:BioMarin to Present at the Cowen and Company 29th Annual Health Care Conference 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: